menu
    • menu

    Company profile for Crescita Therapeutics

    NEW Drugs in Dev: 2
    Coral

    Virtual Booth

    Contact Supplier

    China’s top API & intermediate manufacturer, delivering advanced CMO/CDMO solutions to 60+ countries, empowering global health progress

    Virtual Booth

    Contact Supplier

    AMI Lifesciences is Driven by Chemistry. Powered by People.

    Virtual Booth

    Contact Supplier

    ChemWerth works in generic API development & supply, non-infringement patent strategy development and regulatory support.

    Virtual Booth

    Contact Supplier

    Alchem offers Botanical APIs for Pharmaceuticals, Cosmetics and Nutraceuticals// FDA-inspected and EU-GMP certified.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-04-20

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    INSPECTIONS & REGISTRATIONS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Crescita (TSX:CTX) is a publicly traded, Canadian commercial dermatology company with a portfolio of non-prescription skincare products and prescription drug products for the treatment and care of skin conditions and diseases and their symptoms. Crescita owns multiple proprietary drug delivery platforms that support the development of patented formulations that can facilitate the delivery of active drugs into or through the s...
    Crescita (TSX:CTX) is a publicly traded, Canadian commercial dermatology company with a portfolio of non-prescription skincare products and prescription drug products for the treatment and care of skin conditions and diseases and their symptoms. Crescita owns multiple proprietary drug delivery platforms that support the development of patented formulations that can facilitate the delivery of active drugs into or through the skin. Crescita owns a portfolio of non-prescription skincare products and has one FDA approved prescription product. Crescita owns the sales and marketing rights in Canada and Mexico

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Crescita TherapeuticsCanada Flag
    Country
    Country
    Canada
    Address
    Address
    2805 Place Louis-R Renaud Laval, Québec, H7V 0A3
    Telephone
    Telephone
    (905) 673-4295
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.crescitatherapeutics.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/crescita-therapeutics-inc./
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    PEGS Boston Summit

    PEGS Boston Summit

    Not Confirmed

    envelop Contact Supplier

    PEGS Boston Summit

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Crescita Announces Final Shareholder Payment in ClinActiv Deal
    Crescita Announces Final Shareholder Payment in ClinActiv Deal

    01 Jun 2026

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20260601323162/en/Crescita-Therapeutics-Inc.-Announces-Final-Consideration-Payable-to-Shareholders-Pursuant-to-Arrangement-with-ClinActiv

    BUSINESSWIRE
    01 Jun 2026
    Share Share
    Crescita Therapeutics Obtains Final Order for Plan of Arrangement
    Crescita Therapeutics Obtains Final Order for Plan of Arrangement

    20 May 2026

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20260520975196/en/Crescita-Therapeutics-Inc.-Obtains-Final-Order-Approving-Plan-of-Arrangement

    BUSINESSWIRE
    20 May 2026
    Share Share
    Crescita Shareholders Approve Acquisition by ClinActiv Holdings
    Crescita Shareholders Approve Acquisition by ClinActiv Holdings

    14 May 2026

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20260514592595/en/Crescita-Obtains-Shareholder-Approval-To-Be-Acquired-By-ClinActiv-Holdings

    BUSINESSWIRE
    14 May 2026
    Share Share
    Crescita Reports First Quarter 2026 Results
    Crescita Reports First Quarter 2026 Results

    11 May 2026

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20260511658083/en/Crescita-Reports-First-Quarter-2026-Results

    BUSINESSWIRE
    11 May 2026
    Share Share
    Crescita Reports Q4 and Fiscal 2025 Results
    Crescita Reports Q4 and Fiscal 2025 Results

    31 Mar 2026

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20260331480395/en/Crescita-Reports-Q4-and-Fiscal-2025-Results

    BUSINESSWIRE
    31 Mar 2026
    Share Share
    Crescita Reports Third Quarter 2025 Results
    Crescita Reports Third Quarter 2025 Results

    05 Nov 2025

    // BUSINESS WIRE

    https://www.businesswire.com/news/home/20251105811549/en/Crescita-Reports-Third-Quarter-2025-Results

    BUSINESS WIRE
    05 Nov 2025
    Share Share

    Inspections and registrations

    Upload your audits for free, ask us

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search